Selective serotonin reuptake inhibitors (SSRIs [fluoxetine, sertraline, paroxetine]) and the selective norepinephrine reuptake inhibitor (SNRI) venlafaxine, as well as clonidine and gabapentin, reduce hot flashes by about 25% (approximately one per day) in women with and without a history of breast cancer. No studies compare medications against each other to determine a single best option.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
clinical inquiry
4
inquiry nonhormonal
4
nonhormonal treatments
4
treatments effective
4
effective hot
4
hot flashes?
4
flashes? selective
4
selective serotonin
4
serotonin reuptake
4
reuptake inhibitors
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!